Literature DB >> 21329636

Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.

K Fujisaki1, A Ono-Fujisaki, N Kura-Nakamura, N Komune, N Hirakawa, K Tsuruya, S Komune, M Iida.   

Abstract

Gadolinium (Gd)-based contrast media were introduced as alternatives to iodinated media for magnetic resonance imaging (MRI). Although originally thought to be non-nephrotoxic, Gd-based contrast media have recently been reported to be associated with acute kidney injury. The underlying mechanism of Gd-induced renal injury is not completely understood. We report an 80-year-old patient with buccal mucosa cancer for whom MRI with Gd-based contrast agent was conducted 3 times within 3 weeks. The patient developed rapid deterioration of preexisting renal insufficiency, and developed uremic symptoms and pulmonary edema. The patient was hemodialyzed 3 times. This resulted in improvement of renal function and clinical symptoms. This case emphasizes the potential nephrotoxicity of Gd-based contrast media and suggests that renal insufficiency, diabetes mellitus, old age and high dose of Gd-based contrast medium are risk factors for acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329636     DOI: 10.5414/cnp75251

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.

Authors:  Leonardo Victor Barbosa Pereira; Maria Heloisa Massola Shimizu; Lina Paola Miranda Ruiz Rodrigues; Cláudia Costa Leite; Lúcia Andrade; Antonio Carlos Seguro
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

2.  Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function.

Authors:  Brankica Spasojević-Dimitrijeva; Jelena Kotur-Stevuljević; Milan Đukić; Dušan Paripović; Gordana Miloševski-Lomić; Vesna Spasojević-Kalimanovska; Polina Pavićević; Jadranka Mitrović; Mirjana Kostić
Journal:  Med Sci Monit       Date:  2017-09-06

Review 3.  Contrast-induced acute kidney injury: A review of practical points.

Authors:  Sercin Ozkok; Abdullah Ozkok
Journal:  World J Nephrol       Date:  2017-05-06

4.  Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury.

Authors:  Ebru Gok Oguz; Ahmet Kiykim; Kenan Turgutalp; Refik Olmaz; Onur Ozhan; Necati Muslu; Mehmet Horoz; Simge Bardak; Mehmet Ali Sungur
Journal:  Med Sci Monit       Date:  2013-11-06

Review 5.  Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives.

Authors:  Ethel J Ngen; Dmitri Artemov
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 6.208

6.  Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals.

Authors:  Laura K Young; Shona Z Matthew; J Graeme Houston
Journal:  Eur Radiol       Date:  2018-10-01       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.